Ciapponi, A. (2024) “Trastuzumab-emtansine versus other anti-HER2 regimens in early or unresectable or metastatic HER2 positive breast cancer: systematic review and network meta-analysis”, Revista Peruana de Medicina Experimental y Salud Pública, 41(1), pp. 7–18. doi:10.17843/rpmesp.2024.411.13351.